|
|
|
| ||||||
Last Loaded on Web: Monday, April 01, 2013
EMCare is Elsevier's database on all nursing specialities and healthcare professions. EMCare includes coverage of allied health, education and training, development and management, midwifery, health and health care economics, clinical medical and health care social work, psychiatry and mental health, and traumatology, critical care medicine. All specialities of nursing are covered, including (but not limited to) addictions nursing, coronary care, flight nursing, hospice and palliative care, neonatal nursing, occupational health, perioperative nursing, psychiatric nursing, school health nursing, urologic nursing, burn nursing, community and mental health, gastroenterology nursing, gynaecologic nursing, HIV/AIDS nursing, professional home nursing, medical-surgical nursing, obstetric nursing, paediatric nursing, respiratory nursing and plastic surgical nursing.
The database provides the full author abstract for about 75% of articles in all, and about 85% of current articles. Articles are indexed with EMTREE terms from Elsevier's Life Science Thesaurus, which has been comprehensively expanded with nursing terms. Articles are indexed within 15 days of receipt and are online very soon after that. Both trade journals and electronic-only journals from around the world are included.
USE EXPLODE(!)to retrieve all narrower descriptors: S PHARMACOGENETICS!USE THE ONLINE THESAURUSto find EMTREE preferred terms: E (ULCER)USE TN AND MNto find manufacturer and trade names in relevant records S TN=BAYER
|
EMCare covers all specialties of nursing, including:
EMCare has about 2,700 currently published journals and a further 900 relevant ceased titles. A little more than half of the journals are shared with EMBASE. Relevant coverage from MEDLINE is included, and about 67% of CINahl's journals are included in EMCare.
| Dates Covered: | 1995 to the present |
|---|---|
| File Size: | More than 2.4M records as of November 2008 |
| Update Frequency: | Weekly |
The following search aids are available in the Dialog Library:
| ACRONYM | CATEGORY NAME |
|---|---|
| ALTMED | Alternative Medicine |
| BIOCHEM | Biochemistry |
| BIOSCI | Biosciences |
| BIOTECH | Biotechnology |
| BRANDNMS | Brand Names |
| HEALTH | Health |
| MEDDEV | Medical Devices |
| MEDICINE | Medicine |
| NURSING | Nursing and Health Administration |
| PHARM | Pharmacology |
| SAFETY | Safety |
|
EMCare is provided by Elsevier B.V. Questions concerning file content should be directed to: P.O. Box 211 Amsterdam, 1000 AE The Netherlands
|
For Dialog's Redistribution and Archive Policy, enter HELP ERA online. Note, however, that EMCARE has a separate Archive policy and data may only be held in electronic form for a maximum period of 12 months from the date it is first downloaded and must then be deleted. Those customers that want to archive beyond 12 months should contact their Account Manager or nearest Customer Services desk to obtain an extended archiving license. The following terms and conditions also apply.
The database is owned and copyrighted by Elsevier B.V. NEITHER ELSEVIER NOR ANY OF ITS AFFILIATES OR LICENSORS SHALL BE LIABLE TO YOU OR ANYONE ELSE FOR ANY LOSS OR INJURY, CAUSED IN WHOLE OR PART BY ITS NEGLIGENCE OR CONTINGENCIES BEYOND ITS CONTROL IN PROCURING, COMPILING, INTERPRETING, REPORTING, OR DELIVERING INFORMATION THROUGH THE SITE. IN NO EVENT WILL ELSEVIER, ITS AFFILIATES OR LICENSORS BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE ON SUCH INFORMATION. ELSEVIER AND ITS AFFILIATES AND LICENSORS SHALL NOT BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DAMAGES (INCLUDING, WITHOUT LIMITATION, CONSEQUENTIAL, SPECIAL, INCIDENTAL, INDIRECT, OR SIMILAR DAMAGES) EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or advertised on our system.
| File 45:EMCare 2008/Nov W2 | |
| (c) 2008 Elsevier B.V. | |
| AA= | 0005399357 EMCARE No: 352128423 |
| /TI | Quality assurance indicators for risk management in the follow-up of |
| medical care received by acute ischemic stroke patients | |
| Des indicateurs de qualite et de gestion des risques pour suivre la prise | |
| en charge hospitaliere des accidents vasculaires cerebraux | |
| AU= | Le Barbier M.; Deltour S.; Crozier S.; Leger A.; Pires C.; Rufat P.; |
| Samson Y.; Bourdillon F. | |
| CS= | AP-HP Departement de Biostatistiques, de Sante Publique et Information |
| Medicale, 3e etage Batiment Mazarin, Groupe Hospitalier | |
| Pitie-Salpetriere, 75651 Paris Cedex 13 | |
| CS= | CORRESP. AUTHOR/AFFIL: Bourdillon F.: AP-HP Departement de |
| Biostatistiques, de Sante Publique et Information Medicale, 3e etage | |
| Batiment Mazarin, Groupe Hospitalier Pitie-Salpetriere, 75651 Paris Cedex | |
| 13 | |
| JN=,SO=,CP=,PD=,PY= | Sante Publique ( Sante Publique ) (France) May 1, 2008, 20/3 (225-237) |
| PU= | PUBLISHER: Societe Francaise de Sante Publique |
| CD=,SN= | CODEN: SAPUE ISSN: 0995-3914 |
| DT=,RT= | DOCUMENT TYPE: Journal; Article RECORD TYPE: Abstract |
| LA=,SL= | LANGUAGE: French SUMMARY LANGUAGE: English; French |
| NUMBER OF REFERENCES: 32 | |
| /AB | Although recommendations for diagnosis and treatment of stroke are |
| available, the aim of this study was to identify indicators of quality and | |
| risk management for acute ischemic stroke hospital patients. We conducted a | |
| descriptive study of stroke patients who were diagnosed less than 12 hours | |
| before admission to the Pitie-Salpetriere hospital's neurology and stroke | |
| unit. Data were collected using a literature review and from existing | |
| recommendation. During the study period (August 2003 through April 2005) | |
| 310 eligible patients were identified. In 87.5% of the cases, patients | |
| suffered from a cerebral infarction and in 10.3% from an intracranial | |
| haemorrhage. The initial deficit was mild to severe. The average time | |
| between the first symptoms and admission in the stroke unit was 212 +/- 130 | |
| minutes. Forty percent of patients who underwent a thrombolysis did so | |
| within the first 3 hours. The average length of stay in the stroke unit was | |
| 17.5 days. Thirty-one percent of the patients were discharged to go home, | |
| 47% to a rehabilitation unit and 8% died. Ten indicators of quality and | |
| risk management are proposed, taking in account the events before | |
| admission, hospital care, side effects, duration of stay, discharge | |
| location and the handicap. | |
| /DE | DESCRIPTORS: |
| *blood clot lysis; *cerebrovascular accident; *follow up; *medical care; * | |
| quality control; *risk management; *stroke patient | |
| brain hemorrhage; brain infarction; diagnosis; disability; hospital; | |
| hospital care; hospital patient; length of stay; neurology; patient; | |
| rehabilitation; side effect; stroke; stroke unit |
| SEARCH SUFFIX |
DISPLAY CODE |
FIELD NAME |
INDEXING |
SELECT EXAMPLES |
|---|---|---|---|---|
| None | None | All Basic Index Fields | Word | S ANDROGEN(W)RECEPTOR |
| /AB | AB | Abstract1 | Word | S RISK(W)MANAGEMENT/AB |
| /DE | DE | Descriptor (All)2 | Word & Phrase |
S QUALITY(W)CONTROL/DE S FOLLOW UP/DE |
| /ID | ID | Identifier3 | Word & Phrase |
S INFORMAL(W)CARE(W)TIME/ID S PRIMARY CARE PHYSICIAN/ID |
| /MD | MD | Device Manufacturer4 | Word & Phrase |
S EDWARDS(W)LIFESCIENCES/MD S EDWARDS LIFESCIENCES/MD |
| /MN | MN | Drug Manufacturer4 | Word & Phrase |
S PHARBIO(W)MEDICAL/MN S PHARBIO MEDICAL?/MN |
| /ND | ND | Device Name4 | Word & Phrase |
S CARDIO(W)Q/ND S CARDIO Q/ND |
| /TI | TI | Title | Word | S ISCHEMIC(W)STROKE/TI |
| /TN | TN | Drug Brand Name4 | Word & Phrase |
S AGGRENOX/TN S CC 4047/TN |
1 Abstracts included for approximately 75% of the records.
3 Also /IF. The Identifier field contains EMTREE terms.
4 Searchable in the Basic Index and in the Additional Indexes.
| SEARCH PREFIX |
DISPLAY CODE |
FIELD NAME |
INDEXING |
SELECT EXAMPLES |
|---|---|---|---|---|
| AA= | AA | EMBASE ID Number | Phrase | S AA=352128423 |
| AU= | AU | Author | Phrase | S AU=LE BARBIER M. |
| None | AZ | DIALOG Accession Number | ||
| CD= | CD | CODEN | Phrase | S CD=SAPUE |
| CP= | CP | Country of Publication | Word & Phrase |
S CP=FRANCE S CP=UNITED STATES |
| CS= | CS | Corporate Source | Word & Phrase |
S CS=(AP(W)HP(F)BIOSTASTIQUES) S CS=AP-HP DEPARTEMENT? |
| DT= | DT | Document Type | Phrase | S DT=JOURNAL |
| None | EL | Author E-mail | ||
| None | II | Publisher Item Identifier | ||
| JN= | JN | Journal Name | Phrase | S JN=SANTE PUBLIQUE |
| LA= | LA | Language | Phrase | S LA=FRENCH |
| LT= | None | Limit Type: Animal Subject5 | Phrase | S LT=ANIMAL |
| MD= | MD | Device Manufacturer4 | Word & Phrase |
S MD=(EDWARDS(W)LIFESCIENCES) S MD=EDWARDS LIFESCIENCES |
| MN= | MN | Drug Manufacturer4 | Word & Phrase |
S MN=(BRISTOL(W)MYERS(W)SQUIBB) S MN=BRISTOL MYERS SQUIBB? |
| ND= | ND | Device Name4 | Word & Phrase |
S ND=(CARDIO(W)Q) S ND=CARDIO Q? |
| NO= | NO | Article Number | Phrase | S NO=4561955 |
| PD= | PD | Publication Date | Phrase | S PD=20080501 |
| PU= | PU | Publisher | Word | S PU=(SOCIETE(W)FRANCAISE(1W)SANTE) |
| PY= | PY | Publication Year | Phrase | S PY=2008 |
| None | RF | Number of References | ||
| RT= | RT | Record Type | Phrase | S RT=ABSTRACT |
| SL= | SL | Summary Language | Phrase | S SL=FRENCH |
| SN= | SN | International Standard Serial Number (ISSN) | Phrase | S SN=0995-3914 S SN=09953914 |
| SO= | SO | Source Information6 | Word | S SO=(SANTE(W)PUBLIQUE) |
| SQ= | SQ | Molecular Sequence Number | Phrase | S SQ=N21294 |
| TL= | TL | Clinical Trials Number | Phrase | S TL=NCT00342745 |
| TN= | TN | Drug Brand Name4 | Word & Phrase |
S TN=AGGRENOX S TN=CC 4047? |
| UD= | None | Update | Phrase | S UD=9999 |
5 To Limit to Animal Subjects, S S1 AND LT=ANIMAL
6 Display includes Journal Name, Volume, Issue, Pagination, and Publication Date.
| SUFFIX | FIELD NAME | EXAMPLES |
|---|---|---|
| /ABS | Abstract Present | S ISCHEMIC(W)STROKE/ABS |
| /ENG | English Language | S S1/ENG |
| /HUMAN | Human Subject | S COMPARATIVE STUDY/HUMAN |
| /MAJ | Major Descriptor | S VACCINE/MAJ |
| /NOABS | No Abstract Present | S S2/NOABS |
| /NONENG | Non-English Language | S STEM CELL/NONENG |
| /YYYY | Publication Year | S S3/2007:2008 |
| SORTABLE FIELDS | EXAMPLES |
|---|---|
| AU, CS, JN, PD, PY, TI | SORT S2/ALL/AU SORT S4/ALL/PY,D |
| RANK FIELDS | EXAMPLES |
|---|---|
| All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Other RANK codes include: DE, ID, RT | RANK DE S3 RANK AU S4 |
| User-defined formats may be specified using the display codes indicated in the Search Options tables. | TYPE S3/AU,TI,SO/1-5 PRINT S1/AU,AB/ALL |
| NO. |
DIALOGWEB FORMAT |
RECORD CONTENT |
|---|---|---|
| 1 | -- | DIALOG Accession Number |
| 2 | -- | Full Record except Abstract |
| 3 | Medium | Bibliographic Citation |
| 4 | -- | Full Record with Tagged Fields1 |
| 5 | -- | Full Record1 |
| 6 | Free | Title and Publication Year |
| 7 | Long | Bibliographic Citation and Abstract1 |
| 8 | Short | Title, Indexing, and Publication Year |
| 9 | Full | Full Record1 |
| K | -- | KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats |
| FIELD NAME | EXAMPLES | ||
|---|---|---|---|
| DIALOG Accession Number | TYPE 1889668/5 DISPLAY 1888823/AU,TI PRINT 1390632/5 |
||
Rates For File: EMCare®[45]
Cost per DialUnit: $6.36
Cost per minute: $1.68
Rank Elements $0.00
ALERT (default) $11.75
ALERT (Monthly) $47.00
ALERT (Biweekly/twice a month) $23.00
ALERT (Weekly) $11.75
ALERT (Daily) * $11.50
ALERT (Calendar weekly) * $11.75
ALERT (Intraday) * $11.50
* = custom scheduled Alerts only
ALERT Number of included prints 0
Format Types Prints
1 $0.00 $0.00
2 $3.00 $3.00
3 $3.00 $3.00
4 $3.00 $3.00
5 $3.00 $3.00
6 $0.00 $0.00
7 $3.00 $3.00
8 $0.00 $0.00
9 $3.00 $3.00
KWIC95 $0.20 NA
KWIC96 $0.20 NA
REDIST/COPY Multiplier Table:
Range Multiplier
1-2 1.00
3-25 1.50
26-100 3.00
101-200 4.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
ARCHIVE Multiplier Table:
Range Multiplier
1-25 1.50
26-200 3.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
